Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
December 14 2021 - 9:31AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For
the month of December 2021
Commission
File Number 001-37381
MEDIGUS LTD.
(Translation of registrant’s name into English)
3
HaNechoshet Street, building B, 6971068, Tel Aviv, Israel
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): __
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): __
EXPLANATORY
NOTE
Medigus
Ltd. hereby furnishes its corporate presentation, which is attached to this Form 6-K as Exhibit 99.1.
EXHIBIT
INDEX
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
Date:
December 14, 2021
|
By:
|
/s/
Tali Dinar
|
|
|
Tali
Dinar
|
|
|
Chief
Financial Officer
|
- 3 -
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Medigus (NASDAQ:MDGS)
Historical Stock Chart
From Apr 2023 to Apr 2024